Tell us about your experience with SFA Treatments

The survey will also be available at the PVI 2024 session entitled “Newest tool and technologies on the PAD treatment horizon”, on Friday 13 December at 8.15am, where you can debate the results live!

Question Title

* What is your country of practice?

Question Title

* What is your primary medical specialty?

Question Title

* On average, how many endovascular SFA/popliteal procedures have you and your team performed per month over the past 12 months?

Question Title

* For de novo lesions (TASC A and B, less than 15 cm) in the SFA/popliteal artery that you have treated with an endovascular approach in the last 12 months, which of the following therapies do you typically use as the primary treatment (assuming no complications)?
Maximum 2 choices

Plain Balloon Angioplasty

Paclitaxel coated balloon

Limus coated balloon

Bare Metal Stent

Paclitaxel eluting stent

Limus eluting stent

Other (please specify)

Question Title

* For de novo lesions (Tasc C and D more than 15cm) in the SFA/popliteal artery that you have treated with an endovascular approach in the last 12 months, which of the following therapies do you typically use as the primary treatment (assuming no complications)?
Maximum 2 choices

Plain Balloon Angioplasty

Paclitaxel coated balloon

Limus coated balloon

Bare Metal Stent

Paclitaxel eluting stent

Limus eluting stent

Other (please specify)

Question Title

* For re-stenosis lesion in the SFA/popliteal artery that you have treated with an endovascular approach in the last 12 months, which of the following therapies do you typically use as the primary treatment (assuming no complications)?

Plain Balloon Angioplasty

Paclitaxel coated balloon

Limus coated balloon

Bare Metal Stent

Paclitaxel eluting stent

Limus eluting stent

Other (please specify)

Question Title

* For SFA/popliteal lesions, when do you prefer to treat with 0.018 platforms vs 0.035?
Please select all that apply

In complex lesions/angioplasties

In chronic total occlusions

In case of radial approach

For outpatient approach

Other, please comment:

Tell us about your experience with SFA Treatments

Question Title

* What is your country of practice?

Question Title

* What is your primary medical specialty?

Question Title

* On average, how many endovascular SFA/popliteal procedures have you and your team performed per month over the past 12 months?

Question Title

* For de novo lesions (TASC A and B, less than 15 cm) in the SFA/popliteal artery that you have treated with an endovascular approach in the last 12 months, which of the following therapies do you typically use as the primary treatment (assuming no complications)? Maximum 2 choices

Question Title

* For de novo lesions (Tasc C and D more than 15cm) in the SFA/popliteal artery that you have treated with an endovascular approach in the last 12 months, which of the following therapies do you typically use as the primary treatment (assuming no complications)?Maximum 2 choices

Question Title

* For re-stenosis lesion in the SFA/popliteal artery that you have treated with an endovascular approach in the last 12 months, which of the following therapies do you typically use as the primary treatment (assuming no complications)?

Question Title

* For SFA/popliteal lesions, when do you prefer to treat with 0.018 platforms vs 0.035? Please select all that apply

* For de novo lesions (TASC A and B, less than 15 cm) in the SFA/popliteal artery that you have treated with an endovascular approach in the last 12 months, which of the following therapies do you typically use as the primary treatment (assuming no complications)?
Maximum 2 choices

* For de novo lesions (Tasc C and D more than 15cm) in the SFA/popliteal artery that you have treated with an endovascular approach in the last 12 months, which of the following therapies do you typically use as the primary treatment (assuming no complications)?
Maximum 2 choices

* For SFA/popliteal lesions, when do you prefer to treat with 0.018 platforms vs 0.035?
Please select all that apply